Follow
Bharat Kumar Devapatla
Bharat Kumar Devapatla
University of Oklahoma
Verified email at cytovance.com - Homepage
Title
Cited by
Cited by
Year
Chebulagic acid, a COX–LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line
DB Reddy, TCM Reddy, G Jyotsna, S Sharan, N Priya, V Lakshmipathi, ...
Journal of ethnopharmacology 124 (3), 506-512, 2009
2172009
Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-κB and MAPK activation in RAW 264.7 macrophages
DB Reddy, P Reddanna
Biochemical and Biophysical Research Communications 381 (1), 112-117, 2009
2062009
Anti-leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation
TC Reddy, DB Reddy, A Aparna, KM Arunasree, G Gupta, C Achari, ...
Toxicology in vitro 26 (3), 396-405, 2012
1022012
Identification and evaluation of antioxidant, analgesic/anti-inflammatory activity of the most active ninhydrin–phenol adducts synthesized
KR Prabhakar, VP Veerapur, P Bansal, KP Vipan, KM Reddy, A Barik, ...
Bioorganic & medicinal chemistry 14 (21), 7113-7120, 2006
712006
CXCR2 inhibition combined with sorafenib improved antitumor and antiangiogenic response in preclinical models of ovarian cancer
B Devapatla, A Sharma, S Woo
PLoS One 10 (9), e0139237, 2015
572015
The Soybean-Derived Peptide Lunasin Inhibits Non-Small Cell Lung Cancer Cell Proliferation by Suppressing Phosphorylation of the Retinoblastoma Protein.
E McConnell, B Devapatla, K Yadanapudi, K Davis
Oncotarget, 2014
492014
High-throughput screening assays for cyclooxygenase-2 and 5-lipoxygenase, the targets for inflammatory disorders
KA Kumar, TC Reddy, GV Reddy, D Reddy, SVK Mahipal, S Sinha, ...
NISCAIR-CSIR, India, 2011
272011
Multifunctional APJ pathway promotes ovarian cancer progression and metastasis
D Neelakantan, S Dogra, B Devapatla, P Jaiprasart, MC Mukashyaka, ...
Molecular Cancer Research 17 (6), 1378-1390, 2019
262019
Synthesis of 2-aryl-7-(3-oxo-2H-[1,4]-benzoxazin-6-yl)pyrazolo[1,5- ]pyrimidines as potential COX-2-inhibitors
GJ Reddy, S Sailaja, KS Rao
CSIR, 2005
192005
Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin
B Devapatla, C Shidal, K Yaddanapudi, KR Davis
F1000Research 5, 2016
132016
Identification of signature genes associated with therapeutic resistance to anti-VEGF therapy
P Jaiprasart, S Dogra, D Neelakantan, B Devapatla, S Woo
Oncotarget 11 (1), 99, 2020
122020
Genetically determined inflammatory-response related cytokine and chemokine transcript profiles between mammary carcinoma resistant and susceptible rat strains
B Devapatla, J Sanders, DJ Samuelson
Cytokine 59 (2), 223-227, 2012
72012
Apelin/apj pathway for targeting ovarian tumor microenvironment
BK Devapatla, P Jaiprasart, S Dogra, J Ha, S Woo
Cancer Research 76 (14_Supplement), 1272-1272, 2016
52016
Futures trade, export and direction of trade in soya: an econometric analysis
D Reddy
UAS, Dharwad, 2008
42008
Price trends in soyabean and integration of markets for soyabean and soya oil.
RA Yeledhalli, B Banakar, K Vilas
Karnataka Journal of Agricultural Sciences 22 (2), 359-362, 2009
32009
Metabolism of arachidonic acid in sheep uterus: In vitro studies
AS Padma, S Agarwal, DB Reddy, TS Prasad, P Reddanna
CSIR, 2007
32007
Efficacy of oxfendazole against gastrointestinal nematodes in cattle and buffaloes: a clinical study
D Reddy, Y Muralidhar, V Surya, GS Reddy
J Agric Vet Sci 10, 72-74, 2017
22017
Synthesis of 4H-imidazo[2,1-c][1,4]benzoxazin-4-yl acetic acids and esters as possible COX-2 inhibitors
KN Jayaveera, S Sailaja
CSIR, 2006
22006
Gene and protein expression profiling identifies molecular signature of resistance to anti-VEGF therapy in ovarian cancer
BK Devapatla, P Jaiprasart, S Woo
AACR 74, 2014
12014
Interleukin-8 mediates resistance to anti-VEGF therapy in ovarian cancer
BK Devapatla, A Sharma, S Woo
AACR 74, 2014
12014
The system can't perform the operation now. Try again later.
Articles 1–20